How Long Does the Shingles Vaccine Last?

Shingles (herpes zoster) is a painful viral infection caused by the same virus that causes chickenpox. Vaccination is the best way to prevent or reduce the severity of shingles and its complications. Two vaccines are available:

• Zostavax® (live-attenuated vaccine)
• Shingrix® (recombinant adjuvanted vaccine)

Below is an overview of how long each vaccine’s protection lasts, how that protection fades over time, and what to consider as you age.

---

1. Zostavax®: Live-Attenuated Vaccine

Initial Efficacy

• Recommended for adults aged 60 and older (in some countries as young as 50).
• About 51% reduction in shingles risk during the first year after vaccination.
• Around 67%–88% reduction in the risk of postherpetic neuralgia (long-term nerve pain).

How Protection Fades

• 2–3 years after vaccination: Efficacy against shingles drops to about 40%.
• 5 years after vaccination: Protection falls further, often below 30%.
• 8 years after vaccination: Some studies suggest minimal measurable protection against shingles, though a modest effect on reducing postherpetic neuralgia may remain.

Key Points

• One-time dose.
• Immunity wanes significantly over 5–8 years.
• No approved booster for Zostavax®.
• Often replaced by Shingrix® due to longer-lasting protection.

---

2. Shingrix®: Recombinant Adjuvanted Vaccine

Initial Efficacy

• Recommended for adults aged 50 and older, regardless of past chickenpox or Zostavax® vaccination.
• Clinical trials showed:
  • 97% efficacy in adults 50–59 years old.
  • 91% efficacy in adults 70 years and older.

How Protection Fades

• Year 1–4:
  • Efficacy remains above 85% in most age groups.
  • Waning is modest, about 1%–2% per year.
• Year 5–6:
  • Efficacy still above 75% in adults 50–69 years old.
  • Slightly lower, around 70%–75%, in those 70+.
• Up to Year 9:
  • Data are limited beyond seven years, but models suggest protection remains above 60%–70%.
  • Ongoing studies are evaluating longer-term durability.

Key Points

• Two-dose series, spaced 2–6 months apart.
• Stronger and longer-lasting immune response.
• Preferred vaccine in most guidelines due to sustained high efficacy.
• No booster currently recommended, but future guidance may evolve.

---

3. Factors Influencing Vaccine Duration

Several factors can affect how long shingles vaccine protection lasts:

• Age at vaccination: Younger recipients tend to maintain higher protection longer.
• Immune system health: Chronic conditions or medications that suppress immunity may speed waning.
• Time since vaccination: All vaccines show some decline in protection over years.
• Previous exposure: A history of chickenpox or past zoster episodes can influence immune memory.

---

4. Monitoring and Boosters

• Zostavax®: No booster approved. Protection wanes more rapidly.
• Shingrix®: No booster currently recommended. Expert panels continue to monitor long-term data.
• In the future, booster doses or updated formulations may be considered if protection falls significantly.

---

5. What to Do If You Were Vaccinated Years Ago

1. Check your records: Note which vaccine you received and when.

2. Talk with your doctor: Discuss whether you need re-vaccination with Shingrix® if you had Zostavax®.

3. Stay alert for symptoms: Early treatment is most effective. If you notice tingling, rash, or pain on one side of your body, seek care promptly.

   You can also try a free, online symptom check, using the doctor approved Ubie Symptom Checker.

---

6. Benefits vs. Risks

Benefits

• Significant reduction in shingles cases.
• Lower risk of postherpetic neuralgia (chronic nerve pain).
• Improved quality of life, especially in older adults.

Risks and Side Effects

• Common side effects:
  • Injection-site pain, redness, swelling
  • Mild fever, muscle aches, fatigue
• Serious reactions are rare.
• The risk of serious shingles complications far outweighs vaccine side effects for most adults.

---

7. Practical Tips

• Timing: Ideally vaccinate before age 70, but Shingrix® is licensed from age 50.
• Series completion: With Shingrix®, complete both doses for maximum protection.
• Scheduling: Get the second Shingrix® dose 2–6 months after the first.
• Record keeping: Keep a vaccine card or digital record of dates and type.

---

8. Continuing Protection

Even as vaccine protection wanes:

• Healthy lifestyle supports immunity (balanced diet, exercise, sleep).
• Routine check-ups help monitor overall health.
• Prompt evaluation of nerve pain or rash leads to quicker treatment.

---

9. When to Speak to a Doctor

• If you develop severe, unexplained pain or a shingles-like rash.
• If you’re uncertain about your vaccination status or timing.
• Before starting any new treatments or if you have immune system issues.

For non-emergency guidance, you might also use a free, online symptom check, using the doctor approved Ubie Symptom Checker.

Always speak to a healthcare professional if you suspect life-threatening or serious conditions.

---

10. Bottom Line

• Zostavax®: Protection wanes significantly after 5–8 years; no booster available.
• Shingrix®: High initial efficacy; modest waning (~1%–2% per year); two-dose series recommended.
• Long-term data on Shingrix® are promising but still evolving.
• Consult your doctor about vaccination history and whether re-vaccination is appropriate for you.

Staying informed and discussing your options with a healthcare provider is the best way to ensure you have lasting protection against shingles.